Specifically, mutations of TP53, present in the vast majority of pancreatic cancer (59), confer increased susceptibility to radiosensitization by ATM inhibition/loss that is attributed to differential regulation of apoptosis in P53 mutant versus wild-type tumors (60, 61). The gene discussed is ATM; the disease is pancreatic neoplasm.